FSMDX
Price
$42.33
Change
-$0.12 (-0.28%)
Updated
Jul 31 closing price
Net Assets
52.09B
SFDYX
Price
$30.71
Change
+$0.01 (+0.03%)
Updated
Jul 31 closing price
Net Assets
58.03M
Interact to see
Advertisement

FSMDX vs SFDYX

FSMDX vs SFDYX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. SFDYX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and SFDYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 52.1B vs. SFDYX (58M). FSMDX pays higher dividends than SFDYX: FSMDX (0.76) vs SFDYX (0.68). FSMDX was incepted earlier than SFDYX: FSMDX (15 years) vs SFDYX (11 years). SFDYX (0.74) is less costly to investors than FSMDX (0.03). SFDYX is a more actively managed with annual turnover of: 62.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than SFDYX: FSMDX (0) vs SFDYX (100000). FSMDX annual gain was more profitable for investors over the last year : 18.74 vs. SFDYX (-0.60). FSMDX return over 5 years is better than : 42.85 vs. SFDYX (-2.93).
FSMDXSFDYXFSMDX / SFDYX
Total Expense Ratio0.030.644%
Annual Report Gross Expense Ratio0.030.743%
Fund Existence15 years11 years-
Gain YTD14.62214.492101%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets52.1B58M89,828%
Annual Yield % from dividends0.760.68111%
Returns for 1 year18.74-0.60-3,134%
Returns for 3 years50.0915.51323%
Returns for 5 years42.85-2.93-1,463%
Returns for 10 years165.6442.45390%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX51.730.36
+0.70%
PGIM Quant Solutions Large-Cap Index A
EMAYX20.13N/A
N/A
Gabelli Entpr Mergers & Acquisitions Y
OTCBX18.21-0.02
-0.11%
MFS Mid Cap Growth B
OPMNX28.28-0.08
-0.28%
Invesco Main Street Mid Cap R
BRSDX16.73-0.09
-0.54%
MFS Blended Research Small Cap Eq A